Ocular Therapeutix, Inc. (OCUL) insider trading

{
  "status": "OK",
  "results": [
    {
      "tickers": [
        "OCUL"
      ],
      "issuer_cik": "0001393434",
      "owner_cik": "0001242177",
      "accession_number": "0001104659-26-019256",
      "form_type": "4",
      "filing_date": "2026-02-24",
      "period_of_report": "2026-02-20",
      "issuer_name": "OCULAR THERAPEUTIX, INC",
      "issuer_trading_symbol": "OCUL",
      "owner_name": "LINDSTROM RICHARD L MD",
      "is_director": true,
      "is_officer": false,
      "is_ten_percent_owner": false,
      "is_other": false,
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Common Stock",
      "transaction_timeliness": "O",
      "aff_10b5_one": false,
      "transaction_date": "2026-02-20",
      "transaction_code": "P",
      "equity_swap_involved": false,
      "transaction_shares": 60229,
      "transaction_price_per_share": 7.66,
      "transaction_acquired_disposed": "A",
      "shares_owned_following_transaction": 246933,
      "transaction_value": 461354.14,
      "not_subject_to_section_16": false,
      "direct_or_indirect": "D",
      "footnotes": [
        {
          "id": "F1",
          "description": "The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.64 to $7.69, inclusive. The reporting person undertakes to provide to Ocular Therapeutix, Inc., any security holder of Ocular Therapeutix, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."
        },
        {
          "id": "F2",
          "description": "Includes 43,559 shares transferred from the Lindstrom Family No 2 Limited Partnership to the reporting person."
        }
      ]
    }
  ]
}

// trimmed to 1 results

The response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.